Skip to content

'Getting the Balance Right' - A comparison of physiotherapy and exercise treatments for people with multiple sclerosis (MS)

A randomised controlled trial of physiotherapy and exercise interventions for ambulatory people with multiple sclerosis (MS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN77610415
Enrollment
328
Registered
2009-04-30
Start date
2008-04-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis (MS) Nervous System Diseases Multiple sclerosis

Interventions

The physiotherapy interventions for strands A and B are standardised and based on the latest evidence for practice in order to allow reproduction of the programmes. The yoga and fitness instructor int

Sponsors

University of Limerick (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Both males and females, aged >=18 2. Diagnosis of MS confirmed by their consultant physician or neurologist 3. Resident in the republic of Ireland

Exclusion criteria

Exclusion criteria: 1. Currently experiencing an exacerbation of symptoms due to relapse 2. Patients who have had steroid treatment within 3 months of the baseline measurement 3. Pregnant at time of referral 4. Under 18 years of age

Design outcomes

Primary

MeasureTime frame
Multiple Sclerosis Impact Scale 29, v2 All primary and secondary outcomes will be assessed at the following timepoins: Week 1, (before intervention), week 12 (after intervention/control period) and week 24 (follow-up)

Secondary

MeasureTime frame
1. Muscle strength using hand held dynamometry 2. Modified Ashworth Scale 3. Physiological Cost Index 4. Six-minute walking test 5. Berg Balance Scale 6. Modified Fatigue Impact Scale All primary and secondary outcomes will be assessed at the following timepoins: Week 1, (before intervention), week 12 (after intervention/control period) and week 24 (follow-up)

Countries

Ireland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 2, 2026